Search result for: Pulmonary Embolism

June 2026

Pulmonary Embolism Market Size, Share and Trends 2026 to 2035

  • Report Code : 7882
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global pulmonary embolism market size is estimated to hit around USD 2.70 billion by 2035 increasing from USD 6.04 billion in 2025, with a CAGR of 8.38%.

August 2026

Pulmonary Alveolar Proteinosis (PAP) Drugs Market Size, Key Companies, Product Portfolio, Treatment Trends, Sales Performance, Regulatory Approvals, Company Market Share, and Forecast

  • Report Code : 6635
  • Published : August 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The pulmonary alveolar proteinosis (PAP) drugs market reached USD 859.05 million in 2026, with key pulmonary alveolar proteinosis (PAP) drugs market companies including Savara, Inc., Partner Therapeutics, Inc., Nobelpharma Co., Ltd. Amgen Inc

August 2026

Pulmonary Drug Delivery Systems Market Size, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Clinical Trial Trends, Market Share, and Demand Forecast

  • Report Code : 1502
  • Published : August 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global pulmonary drug delivery systems market size is projected to hit around USD 91.51 billion by 2035 from USD 58.33 billion in 2025, with a CAGR of 4.61%.

March 2026

Pulmonary Arterial Hypertension Market Size, Share and Trends 2025 to 2034

  • Report Code : 3432
  • Published : March 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global pulmonary arterial hypertension market size is expected to increase to USD 13.50 billion by 2034 from USD 8.48 billion in 2025 with a CAGR of 5.30%.

December 2025

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, Share and Trends 2026 to 2035

  • Report Code : 2763
  • Published : December 2025
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The chronic obstructive pulmonary disease treatment market size is expected to hit around USD 33.03 billion by 2035 from USD 21.04 billion in 2025 at a CAGR of 5.14%.